Advanced search
Publication Cover
Future Oncology Latest Articles
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
Plain Language Summary of Publication

A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer

James J Hardinga Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Jia Fanb Zhongshan Hospital of Fudan University, Shanghai, China
,
Do-Youn Ohc Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea
,
Hye Jin Choid Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
,
Jin Won Kime Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
,
Heung-Moon Changf Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
,
Lequn Baog Hubei Cancer Hospital, Wuhan, Hubei, China
,
Hui-Chuan Sunb Zhongshan Hospital of Fudan University, Shanghai, China
,
Teresa Macarullah Vall d´Hebrón University Hospital, Vall d´Hebrón Institute of Oncology (VHIO), Barcelona, Spain
,
Feng Xiei The Third Affiliated Hospital of the Chinese people's Liberation army Naval Military Medical University, Shanghai, China
,
Jean-Phillippe Metgesj CHRU de Brest – Hopital Morvan, ARPEGO Network, Brest, France
,
Jie'er Yingk Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
,
John Bridgewaterl University College London Cancer Institute, London, UK
,
Myung-Ah Leem The Catholic University of Korea, Seoul St Mary's Hospital, Seoul, South Korea
,
Mohamedtaki A Tejanin AdventHealth, Altamonte Springs, FL, USA
,
Emerson Y Cheno Oregon Health & Science University, Portland, OR, USA
,
Dong Uk Kimp Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
,
Harpreet Wasanq Hammersmith Hospital, Imperial College London, London, UK
,
Michel Ducreuxr Université Paris-Saclay, Gustave Roussy, Villejuif, France
,
Yuanyuan Baos BeiGene, Beijing, China
,
Stacie Lindseyt Cholangiocarcinoma Foundation, UT, USA
,
Melinda Bachinit Cholangiocarcinoma Foundation, UT, USA
,
Helen Morementu AMMF – The Cholangiocarcinoma Charity, Stansted, UK
,
Lisa Boykenv Zymeworks Inc., Vancouver, BC, Canada
,
Jiafang Mas BeiGene, Beijing, China
,
Phillip Garfinw Jazz Pharmaceuticals, Palo Alto, CA, USA
,
Shubham Pantx MD Anderson Cancer Center, Houston, TX, USA
& on behalf of the HERIZON-BTC-01 study group show all
Received 26 Jan 2024, Accepted 13 Jun 2024, Published online: 08 Aug 2024

Figures & data

This paper does not have figures.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.